HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A
HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A
复制标题
DOI:
10.1194/jlr.m100343-jlr200
复制
发表时间:
2002-07-01
影响因子:
6.5
通讯作者:
Jones, G
中科院分区:
文献类型:
--
作者:
Chithalen, JV;Luu, L;Jones, G
Two mammalian hCYP26A expression systems have been used to analyze the metabolic products of CYP26A. Through the use of extensive HPLC, UV spectroscopy, and liquid chromatography/tandem mass spectrometry (LC-MS/MS) methodology, we have conclusively demonstrated that the complex mixture of products comprises 4-OH-all-trans-retinoic acid, 4-oxo-all-trans-retinoic acid, and 18-OH-all-trans-retinoic acid, and more polar products, partially identified as dihydroxy and mono-oxo, mono-hydroxy derivatives. These more polar products are presumed to result from multiple hydroxylations on the beta-ionone ring. The inter-relationship of initial and polar metabolites was inferred from both gene-dose and time-course experiments. Both initial and secondary metabolic steps after 4-oxo-all-trans-retinoic acid are ketoconazole-sensitive, suggesting that steps in the production of water-soluble metabolites are cytochrome P450-dependent. HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A.